Our RNA Modifiers

Browse:

Skyhawk's RNA splicing modulators can address a broad range of diseases.

Small Molecules

Skyhawk's small molecules are designed to specifically and selectively bind to RNA pockets.

By modulating RNA with small molecules, Skyhawk can drug targets historically considered "undruggable"

Although 26% of human proteins are considered to be disease-related, only 3% of human proteins are currently druggable using traditional protein-targeting methods  Skyhawk's small molecules are designed to modulate messenger RNA processing upstream of protein production to address an extraordinary range of traditionally ˝undruggable˝ targets.